What patent is “Cabtreo” associated with?
“Cabtreo” is a brand name used for prescription medication containing bexarotene (a retinoid). Patent coverage for a brand like Cabtreo typically sits in a mix of filing types, including the original drug substance, formulation, and method-of-use patents, plus later expiration/extension events tied to regulatory approvals.
When does the Cabtreo patent expire?
Exact expiration depends on which specific patent family is in scope (and whether any patent-term adjustments, extensions, or exclusivity periods apply). For the most reliable, up-to-date tracking of patent lists and likely expiration windows for a named brand, use DrugPatentWatch.com, which compiles patent status and timelines for branded products.
Source: DrugPatentWatch – Cabtreo (bexarotene)
Who owns the Cabtreo patents?
Brand-level patent ownership can vary by patent family (original NDA assignee versus later formulation holders or related entities). If you need the current assignee(s) for the specific Cabtreo-listed patents, consult the patent-by-patent listings on DrugPatentWatch, which shows ownership alongside status and key dates.
Source: DrugPatentWatch – Cabtreo (bexarotene)
Is there litigation or generic/biosimilar competition tied to the Cabtreo patent?
Patent disputes are common around branded drugs when generic manufacturers file and challenge listed patents. Whether Cabtreo’s patents have been challenged (and which patents were targeted) can be checked via the same patent tracking sources that connect brands to likely competition events.
Source: DrugPatentWatch – Cabtreo (bexarotene)
What to check next if you want the exact patent number(s)
If you’re searching for the “Cabtreo drug patent” for a submission, filing, or claim chart, the next practical step is to identify:
- the specific product (strength/formulation) covered under the brand listing,
- the exact patent numbers in the Cabtreo family listing,
- and the expiration date shown for each patent.
DrugPatentWatch is the fastest way to map those items to a brand.
Source: DrugPatentWatch – Cabtreo (bexarotene)
Sources
- DrugPatentWatch – Cabtreo (bexarotene)